These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3013010)

  • 21. Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.
    Urgessa F; Tsegaye A; Gebrehiwot Y; Birhanu A
    BMC Pregnancy Childbirth; 2014 Nov; 14():358. PubMed ID: 25381160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme-linked antiglobulin test.
    Riley JZ; Ness PM; Taddie SJ; Barrasso C; Baldwin ML
    Transfusion; 1982; 22(6):472-4. PubMed ID: 6815839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitation of fetal-maternal hemorrhage by flow cytometry. A simple and accurate method.
    Nance SJ; Nelson JM; Arndt PA; Lam HC; Garratty G
    Am J Clin Pathol; 1989 Mar; 91(3):288-92. PubMed ID: 2493736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consequences of fetomaternal haemorrhage after intrauterine transfusion.
    Nicolini U; Kochenour NK; Greco P; Letsky EA; Johnson RD; Contreras M; Rodeck CH
    BMJ; 1988 Nov; 297(6660):1379-81. PubMed ID: 2464380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.
    Scott JR; Beer AE; Guy LR; Liesch M; Elbert G
    Obstet Gynecol; 1977 Jan; 49(1):9-14. PubMed ID: 401536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy.
    Trolle B
    Acta Obstet Gynecol Scand; 1989; 68(1):45-7. PubMed ID: 2552740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of fetal-maternal haemorrhage in mothers with hereditary persistence of fetal haemoglobin.
    Patton WN; Nicholson GS; Sawers AH; Franklin IM; Ala FA; Simpson AW
    J Clin Pathol; 1990 Sep; 43(9):728-31. PubMed ID: 1698825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of fetal erythrocytes in maternal blood post partum with the fluorescence-activated cell sorter.
    Medearis AL; Hensleigh PA; Parks DR; Herzenberg LA
    Am J Obstet Gynecol; 1984 Feb; 148(3):290-5. PubMed ID: 6421161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages.
    Ness PM; Salamon JL
    Am J Clin Pathol; 1986 May; 85(5):604-6. PubMed ID: 3085471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-D prophylaxis after abortions and interruptions].
    Maas DH
    Fortschr Med; 1979 Jan; 97(4):148-52. PubMed ID: 217809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 35. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fetomaternal incompatibility due to Rhesus erythrocyte antigens other than antigen D].
    Faille N; Kremp O; Risbourg B; Olewniczak G; Maingourd Y; Dieval J; Delobel J
    Ann Pediatr (Paris); 1984 Oct; 31(8):657-60. PubMed ID: 6437316
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rh, Du phenotype in the pregnant woman].
    Lipitz S; Alcalay M
    Harefuah; 1990 Apr; 118(7):386-7. PubMed ID: 2112505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quantification of fetomaternal hemorrhage by an enzyme-linked antibody test with glutaraldehyde fixation.
    Greenwalt TJ; Dumaswala UJ; Domino MM
    Vox Sang; 1992; 63(4):268-71. PubMed ID: 1481475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
    Huchet J; Brossard Y
    Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.